RenovoRx (NASDAQ: RNXT) , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath(R), a novel, FDA-cleare ...

How common is endometrial cancer? In the United States, cancer of the endometrium (the lining of the uterus) is the most common cancer of the female reproductive organs. The American Cancer Society ...

In this undated stock photo, signage for the Center for Disease Control ... data can also have repercussions on planning and ...

The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

AdAlta (ASX:1AD) is bringing cellular immunotherapy products from Asian to western markets to drive value creation.

RenovoRx's innovative RenovoCath and TAMP platform show promising clinical data. Click here to read why RNXT stock presents ...

While some types of cancer can be treated successfully, they may relapse, meaning a complete cure for cancer is not always ...

Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTS™ ...

This initiative aims to enhance access to cancer treatment and support for patients across the country, addressing a critical gap in healthcare services. Listen to Story India is witnessing growing ...

So you can imagine my joy when one of the photo apps on my phone ... need to deal with all the effects of cancer. Support for emotional issues helps a patient retain their sense of self, rather ...